Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
Compounding Theme Archive
PAIN MANAGEMENT

PAIN MANAGEMENT

Permanent storage and easy retrieval of Journal articles and formulations.
  - Includes the full-color, searchable, PDF files of articles and formulations from the Journal.
  - Print Journal articles in color for your research and marketing needs.
  - Eliminate long searches through past issues for articles and formulations.



Only $95.00


(Select Format)
Mailed CD
Instant PDF Download

This archive contains the following articles listed by volume, issue and page number:

PAIN MANAGEMENT RELATED ARTICLES
Title (Click for Details) Vol/Issue Page
NASEM Report on Compounded Topical Pain Creams Vol. 24 No. 6 446
Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse) Vol. 24 No. 5 406
Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream Vol. 24 No. 4 313
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream) Vol. 24 No. 4 320
Tramadol Hydrochloride 10 mg/mL in SyrSpend SF pH4 Vol. 24 No. 4 321
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4 Vol. 24 No. 4 327
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality Vol. 24 No. 3 194
Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules Vol. 24 No. 3 227
Topiramate 5 mg/mL in SyrSpend SF pH4 Vol. 24 No. 2 138
Physicochemical Stability of Ternary Mixtures of Sufentanil, Baclofen, and Ropivacaine in Polypropylene Syringes for Intrathecal Analgesia Vol. 24 No. 2 156
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension Vol. 23 No. 6 486
Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy? Vol. 23 No. 6 496
Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes Vol. 23 No. 4 318
Compounding and Comparative Study of a Superior, Faster, and More Adaptable Lidocaine Dental Gel Formulation Vol. 23 No. 3 250
Acetaminophen 50% Pluronic Lecithin Organogel Gel Vol. 23 No. 2 146
Ketoprofen 10% in Pluronic Lecithin Organogel Vol. 23 No. 2 150
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Vol. 23 No. 1 14
Ketoprofen 10% in Pluronic Lecithin Organogel Vol. 23 No. 1 52
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Vol. 23 No. 1 53
Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes Vol. 23 No. 1 54
Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream Vol. 23 No. 1 82
Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin Vol. 22 No. 6 498
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1 Vol. 22 No. 4 284
Ketoprofen 10% in Pluronic Lecithin Organogel Vol. 22 No. 4 319
Kinetics of Tetracaine Solvolysis in Propylene Glycol Vol. 22 No. 4 329
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension Vol. 22 No. 3 235
The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia Vol. 22 No. 3 252
Prochlorperazine Edisylate 0.5% Nasal Spray Vol. 22 No. 2 150
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome Vol. 22 No. 2 172
Pain: Systematic Review of Pharmacy Compounding of Pain Medication Vol. 22 No. 1 19
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF Vol. 22 No. 1 54
Tolmetin 400-mg Capsules Vol. 21 No. 6 497
Compounding Opportunities in Urology Vol. 21 No. 5 358
Fentanyl Citrate 50-mcg/mL Injection Vol. 21 No. 5 411
Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel Vol. 21 No. 4 314
Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia Vol. 21 No. 4 347
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Vol. 21 No. 3 234
Meloxicam 1% Topical Gel Vol. 21 No. 3 235
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs Vol. 21 No. 2 164
Nifedipine 0.5% Rectal Ointment Vol. 21 No. 1 63
Tetracaine Hydrochloride 0.5% Ophthalmic Solution Vol. 21 No. 1 64
Calculations Vol. 20 No. 6 502
Capsaicin 0.025% and Doxepin 3.3% Cream Vol. 20 No. 6 506
Melatonin 2-mg/mL Oral Suspension Vol. 20 No. 6 512
Menthol, Chloral Hydrate, and Camphor Analgesic Ointment Vol. 20 No. 6 513
Stability of Fentanyl Citrate in Polyolefin Bags Vol. 20 No. 6 514
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial Vol. 20 No. 6 517
Naproxen 5% Cream Vol. 20 No. 5 410
Tetracaine Hydrochloride 2% Topical Solution Vol. 20 No. 5 414
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Vol. 20 No. 3 197
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Vol. 20 No. 3 231
Pain-Away II Headache Capsules Vol. 20 No. 3 233
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Vol. 20 No. 3 247
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Vol. 20 No. 3 250
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Vol. 20 No. 2 107
Blue Goo Anti-Itch Gel Vol. 20 No. 2 144
Medicated Polyox Bandage for Skin Ulcers Vol. 20 No. 2 146
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray Vol. 20 No. 2 147
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Vol. 20 No. 1 50
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules Vol. 19 No. 6 504
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Vol. 19 No. 4 295
Proparacaine Hydrochloride 0.5% Ophthalmic Solution Vol. 19 No. 4 332
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Vol. 19 No. 3 243
Phenazopyridine Hydrochloride 200-mg Capsules Vol. 19 No. 3 245
Physostigmine Salicylate 1-mg/mL Injection Vol. 19 No. 3 246
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles Vol. 19 No. 3 268
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution Vol. 19 No. 2 148
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations Vol. 19 No. 2 161
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time Vol. 19 No. 2 167
Lidocaine Hydrochloride 4% Topical Solution Vol. 19 No. 1 67
Skin Penetration and Antinociception of Topical Gabapentin Formulations Vol. 18 No. 6 504
Sumatriptan Succinate 12-mg/mL Injection Vol. 18 No. 5 416
Compounded Pain Formulations: What is the Evidence? Vol. 18 No. 4 278
Atracurium Besylate 10-mg/mL Injection, Preserved Vol. 18 No. 4 322
Choline Magnesium Trisalicylate Liquid Vol. 18 No. 4 327
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications Vol. 18 No. 3 182
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice Vol. 18 No. 3 190
Bupivacaine Hydrochloride 0.5% Injection Vol. 18 No. 3 234
Butorphanol Tartrate 10-mg/mL Nasal Spray Vol. 18 No. 3 235
Dibucaine 1% Ointment Vol. 18 No. 3 236
Lidocaine Hydrochloride 1% Injection Vol. 18 No. 3 237
Naproxen 25-mg/mL Oral Suspension Vol. 18 No. 3 239
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Vol. 18 No. 3 256
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report Vol. 18 No. 1 14
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C Vol. 18 No. 1 78
Dihydroergotamine Mesylate 1-mg/mL Injection Vol. 17 No. 6 503
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles Vol. 17 No. 6 508
Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream Vol. 17 No. 6 520
Indomethacin 1-mg/mL Injection Vol. 17 No. 5 419
Ketamine 50-mg/mL Injection Vol. 17 No. 4 331
Methohexital Sodium 500-mg/mL Injection Vol. 17 No. 4 332
Buffered Aspirin Capsules Vol. 17 No. 3 228
Naltrexone Hydrochloride 50-mg Capsules Vol. 17 No. 3 235
Alcohol Dehydrated Injection Vol. 17 No. 2 145
Ibuprofen 10-mg/mL Injection Vol. 17 No. 1 67
Mepivacaine Hydrochloride 1% Injection Vol. 17 No. 1 68
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Vol. 16 No. 6 446
Palliative Care and Compounding for Household Pets Vol. 16 No. 6 452
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents Vol. 16 No. 6 462
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules Vol. 16 No. 6 506
Vercuronium Bromide 1-mg/mL Injection Vol. 16 No. 6 509
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report Vol. 16 No. 5 364
Meperidine Hydrochloride 50-mg/mL Injection Vol. 16 No. 5 423
Methocarbamol 100-mg/mL Injection Vol. 16 No. 5 424
Nalbuphine Hydrochloride 10-mg/mL Injection Vol. 16 No. 5 426
Oxymorphone Hydrochloride 1-mg/mL Injection Vol. 16 No. 5 427
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date Vol. 16 No. 5 428
A Concise Discussion of Headache Types, Part 3: Migraine Vol. 16 No. 4 270
Butorphanol Tartrate 2-mg/mL Injection Vol. 16 No. 4 333
Ketorolac Tromethamine 15-mg/mL Injection Vol. 16 No. 4 337
Sufentanil Citrate 50-mcg/mL Injection Vol. 16 No. 4 340
A Concise Discussion of Headache Types, Part 2: Migraine Vol. 16 No. 3 182
Burning Mouth Syndrome: A Discussion of a Complex Pathology Vol. 16 No. 3 196
Alfentanil 500-mcg/mL Injection Vol. 16 No. 3 239
A Concise Discussion of Headache Types, Part 1 Vol. 16 No. 2 125
Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection Vol. 16 No. 2 155
Caffeine Citrate 20-mg/mL Injection Vol. 16 No. 2 156
Stability of Acetyl-L-carnitine in 5% Dextrose Using a High-Performance Liquid Chromatography–Mass Spectrometry Times 2 Method Vol. 16 No. 2 170
Oral Mucositis: Etiology and Clinical and Pharmaceutical Management Vol. 16 No. 1 22
Case Studies of Compounded Tramadol Use in Cats Vol. 16 No. 1 44
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Vol. 15 No. 6 504
Magic Mouthwashes: A Literature Review and Discussion of Common Compositions Vol. 15 No. 5 376
Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Vol. 15 No. 5 386
Transdermals: The Skin as Part of a Drug Delivery System Vol. 15 No. 4 308
Anesthetic Nasal Ointment Vol. 15 No. 4 334
Oxandrolone 1-mg/mL Oral Suspension Vol. 15 No. 4 341
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Vol. 15 No. 3 194
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel Vol. 15 No. 3 242
Diclofenac Sodium 1% Topical Gel Vol. 15 No. 3 243
Ibuprofen 5% Topical Cream Vol. 15 No. 3 244
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel Vol. 15 No. 3 245
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Vol. 15 No. 2 157
PostScription: Commentary: Discussion on the Safety of Topical Prilocaine Vol. 15 No. 2 174
Current Concepts in the Treatment of Recurrent Aphthous Ulcers Vol. 15 No. 1 13
Toxicities Associated with Topical Anesthetics Vol. 15 No. 1 41
Diclofenac Sodium 10-mg/mL Oral Suspension Vol. 15 No. 1 64
Ibuprofen 5% Gel Vol. 15 No. 1 66
Piroxicam 1% Gel Vol. 15 No. 1 69
Pramoxine 1% Cream Vol. 15 No. 1 70
All-Purpose Nipple Ointment: A Compounding Solution to Common Problems with Breastfeeding Vol. 14 No. 6 484
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Vol. 14 No. 6 512
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Vol. 14 No. 6 513
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel Vol. 14 No. 6 514
Capsaicin 0.05% Clear Medication Stick Vol. 14 No. 6 517
Ketoprofen 2% Oral Gel Vol. 14 No. 6 521
"My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care Vol. 14 No. 6 480
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel Vol. 14 No. 6 520
Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients Vol. 14 No. 5 395
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection Vol. 14 No. 5 427
Polidocanol 0.5% Wound Spray Vol. 14 No. 5 429
Acyclovir with Benzocaine Lip Balm Vol. 14 No. 4 332
Acyclovir 5% Lip Balm with Dioxybenzone and Oxybenzone Vol. 14 No. 4 333
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Vol. 14 No. 4 310
Buprenorphine Hydrochloride Injection Vol. 14 No. 4 337
Chloroprocaine Hydrochloride Injection Vol. 14 No. 4 338
Flurbiprofen 5% Bioadhesive Gel for Gingivitis Vol. 14 No. 4 341
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Vol. 14 No. 3 182
Topical Medications for Orofacial Neuropathic Pain Vol. 14 No. 3 200
Managing Pain with Transdermal Ketoprofen Vol. 14 No. 3 204
Potential Treatments for Radiation Dermatitis Vol. 14 No. 3 210
Compounding Gabapentin Suspension for Lower Back Pain in an Older Cat: A Case Report Vol. 14 No. 3 215
Calculations Vol. 14 No. 3 230
Carprofen 2.5-mg/mL Oral Suspension, Veterinary Vol. 14 No. 3 241
Celecoxib 10-mg/mL Oral Suspension Vol. 14 No. 3 242
The Role of Sex Hormones on Fibromyalgia Pain Mediators Vol. 14 No. 3 193
Cohen's Rectal Ointment Vol. 14 No. 3 244
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector Vol. 14 No. 2 160
Tetracaine 4% and Menthol 5% Topical Gel Vol. 14 No. 1 73
Trigger Point Gel Vol. 14 No. 1 75
Topiramate 6-mg/mL Oral Suspension Vol. 13 No. 6 560
Aceclofenac 1.5% Pluronic Lecithin Organogel Vol. 13 No. 5 428
An Abridged History of Aspirin Vol. 13 No. 5 404
Lidocaine 10% Oral Pluronic Lecithin Organogel Vol. 13 No. 5 433
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Vol. 13 No. 5 400
Update on Managing Neuropathic Pain Vol. 13 No. 3 182
Elegant Compounded Solutions for the Treatment of Thrombosed External Hemorrhoids Vol. 13 No. 3 192
Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report Vol. 13 No. 3 196
Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers Vol. 13 No. 3 214
Safe Use of Topical Local Anesthetic Medications for Pain Management Vol. 13 No. 3 218
Calculations Vol. 13 No. 3 239
Analgesic Compound Lotion, Clear Vol. 13 No. 3 240
Hydromorphone Hydrochloride 10-mg/mL Oral Drops Vol. 13 No. 3 241
Lidocaine 2% Popsicle Vol. 13 No. 3 242
Morphine Sulfate 10-mg/mL Oral Solution Vol. 13 No. 3 243
Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel Vol. 13 No. 3 244
Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel Vol. 13 No. 3 245
Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules Vol. 13 No. 3 246
Oxycodone Hydrochloride 20-mg Suppository Vol. 13 No. 3 247
Promethazine 20-mg and Acetaminophen 325-mg Suppositories Vol. 13 No. 3 248
Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules Vol. 13 No. 3 249
Dextromethorphan Hydrobromide 10% and Guaifenesin 10% Rapidly Penetrating Gel Vol. 13 No. 1 66
Tetracaine 0.025% Popsicles Vol. 13 No. 1 73
Equine Anesthesia: Triple Drip Vol. 12 No. 5 402
Aceclofenac 1.5% Gel-Cream Vol. 12 No. 5 446
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration Vol. 12 No. 5 463
Acetaminophen 10-mg/mL Rectal Solution Vol. 12 No. 5 447
Ketoprofen 20% Topical Solution Vol. 12 No. 5 452
Lidocaine Adhesive System Gel Vol. 12 No. 5 453
Piroxicam 5% and Dexpanthenol 5% Gel Vol. 12 No. 5 454
Case Reports: Compounding to Relieve Arthritis Pain Vol. 12 No. 6 498
Glycerin, Sterile Vol. 12 No. 6 542
Indomethacin 2% in Pluronic Lecithin Organogel Vol. 12 No. 6 543
Ketorolac Tromethamine 2% Topical Gel Vol. 12 No. 6 544
Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Vol. 12 No. 6 540
Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel Vol. 12 No. 6 541
Morphine Sulfate 20-mg and Prochlorperazine Maleate 10-mg Troches Vol. 12 No. 6 549
Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration Vol. 12 No. 6 553
Standard Operating Procedure: Dealing with Patients Experiencing Pain: Presenting without a Prescription Vol. 12 No. 3 259
Potassium Nitrate/Benzocaine/Tetracaine Dental Gel Vol. 12 No. 3 266
PreScription: Pain! Vol. 12 No. 3 180
Topical Treatment of Neuropathic Pain Vol. 12 No. 3 182
Compounded Local Anesthetics to Minimize Pain from Medical Procedures Vol. 12 No. 3 192
Dilution and Compounding of Ziconotide for Intrathecal Administration Vol. 12 No. 3 200
Developing a Niche Marketing Strategy Vol. 12 No. 3 242
Chemical Stability of Tramadol Hydrochloride Injection Vol. 12 No. 2 161
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting Vol. 12 No. 2 163
Carbamazepine Topical Preparations Vol. 12 No. 2 150
Hospice and Compounding Pharmacy: Once Inseperable Vol. 12 No. 1 28
Diclofenac Sodium 1% Soft-Patch Gel Vol. 12 No. 1 65
Diclofenac Sodium 1% Soft-Patch Lipophilic Gel Vol. 12 No. 1 66
Flosulide 10-mg/mL Injection Vol. 12 No. 1 69
Piroxicam 1% Soft-Patch Lipophilic Gel Vol. 12 No. 1 71
Piroxicam 1% Soft-Patch Topical Gel Vol. 12 No. 1 72
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen Vol. 11 No. 6 514
Lidocaine Hydrochloride 1.82% Buffered Injection Vol. 11 No. 6 511
Rabbit Medicine Vol. 11 No. 5 364
Diclofenac Sodium 75-mg/mL Injection Vol. 11 No. 5 421
Hydrocortisone 0.5% Ethanolic Gel Vol. 11 No. 5 423
Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution Vol. 11 No. 4 328
Mebeverine Hydrochloride 20% gel Vol. 11 No. 4 330
Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution Vol. 11 No. 4 335
Levorphanol for Excruciating Pain from Oral Cancer: A Case Report Vol. 11 No. 3 212
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Vol. 11 No. 3 220
Calculations - Compounding for Pain Management Vol. 11 No. 3 238
Transdermal Gel in the Treatment of Postoperative Pain Vol. 11 No. 3 181
Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited Vol. 11 No. 3 187
The Rectal Rocket: A Two-Day Treatment for Hemorrhoids Vol. 11 No. 3 194
Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain Vol. 11 No. 3 200
Levorphanol for the Treatment of Severe Chronic Pain Vol. 11 No. 3 202
Aspirin 80-mg/5-mL Oral Liquid, Anhydrous Vol. 11 No. 2 154
Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster Vol. 11 No. 2 131
Principles of Pediatric Palliative Care and Pain Control Vol. 11 No. 1 10
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid Vol. 11 No. 1 71
Dexamethasone 1-mg/mL Oral Liquid Vol. 11 No. 1 72
Chloral Hydrate 50-mg/mL Oral Liquid Vol. 10 No. 6 453
Gabapentin 100-mg/mL Oral Liquid Vol. 10 No. 6 456
Indomethacin 2-mg/mL Oral Liquid Vol. 10 No. 6 458
Migraine: A General Approach to Prevention and Treatment Vol. 10 No. 5 344
Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches Vol. 10 No. 5 351
Midazolam Hydrochloride 1-mg/mL Oral Liquid Vol. 10 No. 5 387
Hospice Symptom Relief Kit: An Update Vol. 10 No. 4 288
Tramadol Hydrochloride 5-mg/mL Oral Liquid Vol. 10 No. 4 307
Tramadol Hydrochloride 7.5-mg/mL and Acetaminophen 65-mg/mL Oral Liquid Vol. 10 No. 4 308
Mexiletine Hydrochloride 10-mg/mL Oral Suspension Vol. 10 No. 3 225
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together Vol. 10 No. 3 237
Chemical Stability of Diclofenac Sodium Injection Vol. 10 No. 2 154
PostScription: Treatment of Chronic Pain with Methadone or Levorphanol Vol. 10 No. 2 159
Hospice from a Compounding Pharmacist's Perspective Vol. 10 No. 2 89
Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh Vol. 10 No. 1 9
Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery Vol. 10 No. 1 14
Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid Vol. 10 No. 1 66
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management Vol. 10 No. 1 69
Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags Vol. 9 No. 6 482
Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain Vol. 9 No. 5 339
Prescription for Relief: One Woman's Experience with Intractable Nonmalignant Pain Vol. 9 No. 5 349
A Patient's Guide to Transdermal Treatment of Pain Vol. 9 No. 5 354
Acetaminophen 400-mg, Aspirin 250-mg, Codeine Phosphate 30-mg with Antacids Capsules Vol. 9 No. 5 386
Acetaminophen 325-mg, Codeine Phosphate 32.5-mg, and Phenyltoloxamine Citrate 30-mg Capsules Vol. 9 No. 5 387
Aspirin 380-mg, Caffeine 30-mg, and Codeine Phosphate 30-mg Capsules Vol. 9 No. 5 388
Aspirin 325-mg, Codeine Phosphate 30-mg, Aluminum Glycinate 48.6-mg, and Magnesium Carbonate 97.2-mg Capsules Vol. 9 No. 5 389
Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection Vol. 9 No. 5 390
Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 12.5-mg Capsules Vol. 9 No. 5 391
Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 25-mg Capsules Vol. 9 No. 5 392
Methadone Hydrochloride 0.33-mg/mL Oral Solution Vol. 9 No. 5 393
Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection Vol. 9 No. 5 394
Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary) Vol. 9 No. 5 395
Bonain's Solution Vol. 9 No. 4 311
Brompton's Mixture Vol. 9 No. 4 312
Dexamethasone Oral Powder 10-mg Units, Veterinary Vol. 9 No. 3 226
Dipyrone 500-mg/mL Injection, Veterinary Vol. 9 No. 3 227
Meloxicam 0.2 mg/mL Oral Liquid, Veterinary Vol. 9 No. 3 228
Piroxicam 2-mg/mL Oral Liquid, Veterinary Vol. 9 No. 3 234
Capsaicin 0.2-mg Troches Vol. 9 No. 2 148
Clobetasol and Dyclonine Oral Paste Vol. 9 No. 2 150
In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride Vol. 9 No. 2 157
Amitriptyline Hydrochloride 10-mg/mL Injection Vol. 9 No. 1 62
Fentanyl 15-mg/mL Injection, Preservative Free Vol. 9 No. 1 63
Gabapentin 2-mg/mL Injection, Preservative Free Vol. 9 No. 1 64
Lidocaine Hydrochloride-2%, Ketolorac Tromethamine-3%, and Clonidine Hydrochloride-0.1% Injection Vol. 9 No. 1 66
Naproxen Sodium 100-mg/mL Injection Vol. 9 No. 1 68
Phenol 8% Injection Vol. 9 No. 1 69
Tolazoline Hydrochloride 25-mg/mL Injection Vol. 9 No. 1 70
Tramadol Hydrochloride 50-mg/mL Injection, Preservative Free Vol. 9 No. 1 71
Compounding for Sports Medicine Vol. 8 No. 6 443
Diclofenac Sodium 25-mg/mL Injection Vol. 8 No. 6 470
Ketamine Hydrochloride and Fentanyl Citrate Injection Vol. 8 No. 6 474
Ketamine 25-mg/mL Nasal Spray Vol. 8 No. 6 475
Lidocaine Hydrochloride 4%, Epinephrine Hydrochloride 0.05%, and Tetracaine Hydrochloride 0.5% Topical Spray Vol. 8 No. 6 476
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink Vol. 8 No. 6 489
Book and Literature Reviews Vol. 8 No. 5 324
Case Report: Diagnosis and Management of Trigeminal Neuralgia and Chronic Paroxysmal Hemicrania in a 43-Year-Old Woman – Oral and Transmucosal Pharmacologic Medications Vol. 8 No. 5 337
Diclofenac Sodium 1.5% Topical Gel Vol. 8 No. 5 387
Ibuprofen 2% Topical Gel Vol. 8 No. 5 388
Book and Literature Reviews Vol. 8 No. 4 244
Migraine Headache Suppositories Vol. 8 No. 3 184
Dicyclomine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches Vol. 8 No. 3 184
Morphine Sulfate 5-mg/0.1-mL Nasal Spray Vol. 8 No. 3 185
Clonidine HCl 0.2%/Gabapentin 6%/Ketamine HCl 10% in Pluronic Lecithin Organogel (PLO) Vol. 8 No. 3 185
Pain Management in the Elderly Vol. 8 No. 3 187
Acyclovir 5%, Lidocaine 1% and Sodium Lauryl Sulfate 5% Medication Stick (Water-soluble base) Vol. 8 No. 3 208
Acyclovir 5%, Lidocaine 1% and Sodium Lauryl Sulfate 5% Medications Stick (Water-proof base) Vol. 8 No. 3 208
Emollient Lip Balm with 5% Benzocaine Vol. 8 No. 3 208
Fever Blister Ointment Vol. 8 No. 3 208
Deoxy-D-Glucose 0.2%, Lidocaine HCl 5% and Sodium Lauryl Sulfate 5% Cream Vol. 8 No. 3 208
Acyclovir 5% and Lidocaine HCl 2% Topical Gel Vol. 8 No. 3 209
Acyclovir 5% and Sodium Lauryl Sulfate 5% Topical Gel Vol. 8 No. 3 209
Acyclovir 5% and Dexamethasone 0.1% Topical Gel Vol. 8 No. 3 209
Foscarnet 3% and Triamcinolone Acetonide 0.1% Topical Gel Vol. 8 No. 3 209
Clonidine HCl 1.5-mg/mL Injection Vol. 8 No. 3 216
Ketoprofen 50-mg Suppository Vol. 8 No. 3 219
Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection Vol. 8 No. 3 220
Sumatriptan 25-mg Suppository Vol. 8 No. 3 221
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Vol. 8 No. 2 101
Hydromorphone HCl 20-mg/mL and Bupivacaine HCl 7.5-mg/mL Injection Vol. 8 No. 2 136
Sore Nipples in Breastfeeding Mothers: Causes and Treatments Vol. 7 No. 6 426
Methadone HCl 2.5-mg Capsules Vol. 7 No. 6 472
Tramadol HCl 100-mg Capsules Vol. 7 No. 6 475
Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers Vol. 7 No. 6 481
Indomethacin 50-mg Suppositories Vol. 7 No. 5 375
Pentazocine HCl 12.5-mg and Aspirin 325-mg Capsules Vol. 7 No. 5 377
Phenylbutazone 100-mg Capsules Vol. 7 No. 5 379
Basics of Compounding for Raynaud's Disease Vol. 7 No. 4 288
Meperidine HCl 100-mg/mL and Atropine Sulfate 0.4-mg/mL Injection Vol. 7 No. 4 300
Meperidine HCl 25-mg/mL and Promethazine HCl 25-mg/mL Injection Vol. 7 No. 4 301
Methocarbamol 400-mg and Aspirin 325-mg Capsules Vol. 7 No. 4 302
The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP Vol. 7 No. 3 180
Dexamethasone Phosphate 0.1% Topical Cream Vol. 7 No. 3 216
Ergotamine Tartrate 2-mg Sublingual Tablets Vol. 7 No. 3 219
Methadone HCl 5-mg/mL Injection Vol. 7 No. 3 221
Ketoprofen 10% in PLO Vol. 7 No. 3 183
Ketamine 10 %, Gabapentin 6%, and Nifedipine 2% in PLO Vol. 7 No. 3 171
PostScription: Sterile Product Admixture Preparation Vol. 7 No. 2 160
Dexamethasone Sodium Phosphate 4-mg/mL Injection Vol. 6 No. 6 450
Hydromorphone HCl 0.1-mg/mL Injection for Patient-Controlled Analgesia Vol. 6 No. 6 454
Methadone HCl 1-mg/mL, 2-mg/mL, and 5-mg/mL Injection Vol. 6 No. 6 455
Morphine Sulfate 2-mg/mL and Droperidol 0.08-mg/mL Injection for Patient-Controlled Analgesia Vol. 6 No. 6 456
Drug Therapy for Acute and Chronic Pain in the Cat Vol. 6 No. 5 338
Basics of Compounding: Phonophoresis Vol. 6 No. 5 362
Ketoprofen 2% Gel for Phonophoresis Vol. 6 No. 5 364
Naproxen 5% Gel for Phonophoresis Vol. 6 No. 5 364
Sodium Salicylate 10% Gel for Phonophoresis Vol. 6 No. 5 364
Hydrocortisone 10% Gel for Phonophoresis Vol. 6 No. 5 364
Dexamethasone 1.5% and Lidocaine HCl 4% Ultrasound Gel Vol. 6 No. 5 365
Ketoprofen 10% in Pluronic Lecithin Organogel Vol. 6 No. 5 368
Basics of Compounding for Iontophoresis, Part II Vol. 6 No. 4 288
Lidocaine HCl 4% Solution for Iontophoresis Vol. 6 No. 4 290
Dexamethasone 4-mg/mL Solution for Iontophoresis Vol. 6 No. 4 290
Acetic Acid 2% Solution for Iontophoresis Vol. 6 No. 4 290
Ketorolac 6-mg/mL Solution for Iontophoresis Vol. 6 No. 4 291
Treatment of Pain with a Topically Applied Combination of Indomethacin and Piroxicam Vol. 6 No. 3 189
Basics of Compounding: Iontophoresis, Part 1 Vol. 6 No. 3 194
Camphor, Menthol, and Eucalyptol Rubefacient Ointment Vol. 6 No. 3 201
Ergoloid Mesylates 15-mg/mL and Selegiline HCl 6.25-mg/mL in PLO Vol. 6 No. 3 203
Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance Vol. 6 No. 1 4
Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective Vol. 6 No. 1 13
Excerpts from and Reviews of Current Published Literature: Pain Management and Disorders of the Oral Cavity Vol. 6 No. 1 19
Analgesic NSAID Suppositories Vol. 6 No. 1 40
Capsaicin 0.075% Topical Spray Vol. 6 No. 1 41
Clonidine HCl 0.2%, Gabapentin 6%, and Ketamine HCl 10% in a Pluronic Lecithin Organogel (PLO) Vol. 6 No. 1 42
Diltiazem HCl 2% Topical Gel Vol. 6 No. 1 43
Fentanyl 10-mcg/mL, Bupivacaine 5-mg/mL, and Baclofen 25-mcg/mL Injection Vol. 6 No. 1 44
Fentanyl 100-mcg/0.1-mL in a Pluronic Lecithin Organogel (PLO) Vol. 6 No. 1 45
Ketoprofen 12.5-mg, Phenyltoloxamine Citrate 30-mg, and Caffeine 30-mg Capsules Vol. 6 No. 1 46
Morphine Sulfate 0.01%-Infused Silver Sulfadiazine (MISS) Cream Vol. 6 No. 1 47
Morphine Sulfate 5-mg/0.1-mL Nasal Spray Vol. 6 No. 1 48
Oxycodone 25-mg Slow-Release Capsules Vol. 6 No. 1 49
Hydrocortisone 10% Phonophoresis Gel Vol. 5 No. 6 454
Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution Vol. 5 No. 6 455
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release Vol. 5 No. 5 401
Sclerotherapy Injections of Phenol for Pain Management Vol. 5 No. 4 308
PostScription: Case Reports and Formulations, George Roentsch, RPh. Vol. 5 No. 2 160
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel Vol. 5 No. 1 44
Fentanyl Troche Protocol Vol. 4 No .6 447
Capsicum Oleoresin 0.3% and Ketoprofen 10% in PLO Gel Vol. 4 No. 5 377
Ketamine for Pain in Hospice Patients Vol. 4 No. 4 253
Custom-Making Medications for the Hospice Patient Vol. 4 No. 4 255
Surviving Cancer - How the Compounding Pharmacist Can Help Vol. 4 No. 4 257
Fentanyl 100-mcg/0.1-mL and Promethazine HCl 12.5-mg/0.1-mL in PLO Vol. 4 No. 4 299
Fentanyl 35-mcg/mL, Bupivacaine HCl 1-mg/mL and Clonidine HCl 9-mcg/mL Intrathecal Solution Vol. 4 No. 4 300
Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers Vol. 4 No. 4 301
Morphine Sulfate 20-mg/mL and Clonidine HCl 10-mcg/mL Epidural Injection Vol. 4 No. 4 303
Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs Vol. 4 No. 4 318
Ketamine HCl 5% and Amitriptyline HCl 2% in PLO Vol. 4 No. 2 132
Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO Vol. 4 No. 2 133
Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium Vol. 4 No. 1 6
The Psychology of Pain Vol. 4 No. 1 12
Opioids: A Review of the Pharmacology Vol. 4 No. 1 17
Fibromyalgia Vol. 4 No. 1 21
Compounding Intrathecal Medications Vol. 4 No. 1 24
Postherpetic Neuralgia Vol. 4 No. 1 27
Amitriptyline HCl 2% and Baclofen 2% in PLO Vol. 4 No. 1 50
Capsaicin 0.075%, Ketamine HCl 2% and Ketoprofen 10% in PLO Vol. 4 No. 1 51
Capsicum 0.32%, Methyl Salicylate 25% and Menthol 10% Analgesic Cream Vol. 4 No. 1 52
Clonidine HCl 1-mg/g in VanPen Cream Vol. 4 No. 1 53
Cyclobenzaprine 1% and Guaifenesin 10% in Speed Gel Vol. 4 No. 1 54
Dyclonine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches Vol. 4 No. 1 55
Fentanyl 50-mcg Chewable Gummy Gels Vol. 4 No. 1 56
Fentanyl 25-mcg/0.1-mL Nasal Spray Vol. 4 No. 1 57
Morphine Sulfate 2.5-mg/mL Inhalation Solution Vol. 4 No. 1 58
Shingles Ointment/Cream Vol. 4 No. 1 59
Osteoarthritis: Other Options Vol. 3 No. 6 433
Case Report: Iontophoresis with Lidocaine and Dexamethasone for Treating Rotator Cuff Injury in a Hockey Player Vol. 3 No. 6 441
Case Reports: Iontophoresis and Phonophoresis for Treating Epicondylitis Vol. 3 No. 6 441
Capsicum and Capsaicin Formulas Vol. 3 No. 6 468
DMSO 70% Topical Solution Vol. 3 No. 6 469
Glucosamine HCl 600-mg Capsules Vol. 3 No. 6 470
Indomethacin 4% Topical Spray Vol. 3 No. 6 471
Iontophoresis Solutions for Arthritis Vol. 3 No. 6 472
Ketoprofen 2.5% in Pluronic Lecithin Organogel Vol. 3 No. 6 473
Methyl Salicylate and Menthol Analgesic Stick Vol. 3 No. 6 475
Piroxicam 1% Alcoholic Gel Vol. 3 No. 6 476
Ultrasonic Preparations for Arthritis Vol. 3 No. 6 477
Compounding for Athletes: Successful Sports Compounds Vol. 3 No. 5 382
The Basics of Compounding: Compounding Gels Vol. 3 No. 5 385
Piroxicam 0.5% in an Alcoholic Gel Vol. 3 No. 5 389
Pluronic Lecithin Organogel (PLO Gel) Vol. 3 No. 5 389
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules Vol. 3 No. 5 409
Fentanyl 20-mcg/mL and Bupivacaine HCl 1.25-mg/mL for Pump Administration Vol. 3 No. 4 301
Morphine Sulfate 50-mg/mL Injection Vol. 3 No. 4 302
Rapid Pharmacokinetic Evaluation of Topical Drug Formulations Vol. 3 No. 4 321
Compounding for Athletes: Tips for Making the Team Vol. 3 No. 3 206
Morphine Sulfate-Dextromethorphan Hydrobromide-Example of capsule with Dry Powder Fill Vol. 3 No. 3 215
Compounding for Athletes: A Primer for Rookies Vol. 3 No. 2 104
The Basics of Compounding: Compounding Creams and Lotions Vol. 3 No. 2 111
Athletic-Analgesic Rub Vol. 3 No. 2 130
Piroxicam 0.5% in Pluronic Lecithin Organogel Vol. 3 No. 2 133
The Basics of Compounding: Compounding Ointments and Pastes Vol. 3 No. 1 22
Topical Ketoprofen for Fibromyalgia Vol. 2 No. 6 433
Ketorolac tromethamine and Ketoprofen suppositories: release profiles and bioavailability of cocoa butter base formula in rabbits Vol. 2 No. 5 390
Antipruritus Suspension (Stop Itch) Vol. 2 No. 4 277
Benzocaine 2% Anesthetic Gel Vol. 2 No. 4 296
Cocaine-Phenol-Tannic Acid Ointment Vol. 2 No. 4 298
Compounding for Pain Management Vol. 2 No. 2 104
Opioids for Noncancer Pain: From Controversy to Consensus Vol. 2 No. 2 106
Phonophoresis with Hydrocortisone 10% in a Highly Viscous Complant Base Vol. 2 No. 2 110
Managing Pain in the Terminally Ill Vol. 2 No. 2 111
The Symptom Relief Kit for Hospice Patients Vol. 2 No. 2 116
Dextromethorphan Hydrobromide and Opioid Tolerance: A Compounding Opportunity for Pharmacists with Chronic Pain Patients Vol. 2 No. 2 118
Profile of a Practice/Patient Handout: DHE Nasal Spray Vol. 2 No. 2 120
Clinical Application of Ketamine Ointment in the Treatment of Sympathetically Maintained Pain Vol. 2 No. 2 122
Buprenorphine HCl 150-mcg/100 mcL Nasal Spray Vol. 2 No. 2 145
Capsaicin 0.05% Topical Gel Vol. 2 No. 2 146
Dexamethasone Sodium Phosphate 1-mg/mL for Iontophoresis Vol. 2 No. 2 147
Dextromethorphan Hydrobromide 30-mg and Morphine Sulfate 10-mg Capsules Vol. 2 No. 2 148
Dihydroergotamine Mesylate 2.5-mg/mL Nasal Spray Vol. 2 No. 2 149
Dihydroergotamine Mesylate 1-mg Troches Vol. 2 No. 2 150
Ergotamine Tartrate, Caffeine, Hyoscyamine Sulfate and Pentobarbital Sodium Suppositories Vol. 2 No. 2 151
Fentanyl 50-mcg Chewable Gummy Gels Vol. 2 No. 2 152
Fentanyl 300-mcg/6-mL Inhalation Vol. 2 No. 2 153
Ketoprofen 10%, Cyclobenzaprine 1% and Lidocaine 5% in Poloxamer Lecithin Organogel Vol. 2 No. 2 154
Lidocaine 30% Lip Balm Vol. 2 No. 2 155
Meperidine HCl 50-mg/mL Nasal Solution Vol. 2 No. 2 156
Morphine Sulfate 25-mg Troche Vol. 2 No. 2 157
Sumatriptan 5-mg/mL Oral Liquid Vol. 2 No. 2 158
Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel Vol. 2 No. 2 159
Dexamethasone and Lidocaine Solution for Iontophoresis Vol. 1 No. 6 410
Ketorolac Solution for Iontophoresis Vol. 1 No. 6 415
Lidocaine HCl 2% Solution for Iontophoresis Vol. 1 No. 6 416
Morphine 10-mg Troches Vol. 1 No. 6 417
Iontophoresis Devices: Clinical Applications for Topical Delivery Vol. 1 No. 6 420
Fentanyl-Bupivacaine-Epinephrine for Epidural Analgesia Vol. 1 No. 5 325
Hydromorphone HCl 10-, 25-, and 50-mg/mL Injections Vol. 1 No. 5 327
Metoclopramide-Lorazepam-Mannitol-Prochlorperazine Antiemetic Injection Vol. 1 No. 5 328
Morphine Sulfate-Bupivacaine HCl Injection Vol. 1 No. 5 330
Morphine Sulfate 10-, 25-, and 50-mg/mL Injections (Preservative Free) Vol. 1 No. 5 331
Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease Vol. 1 No. 4 242
Beclomethasone Dipropionate 1.25 mg/mL Aerosol Solution-Veterinary Vol. 1 No. 4 243
Fentanyl and Bupivacaine Injection for Ambulatory Pump Reservoir Vol. 1 No. 3 178
Piroxicam 2% in an Alcoholic Gel Vol. 1 No. 3 181
Stability of Ketorolac Tromethamine in 5% Dextrose Injection and 0.9% Sodium Chloride Injections Vol. 1 No. 3 206
Rectal and Stomal Administration of Analgesic Suppositories Vol. 1 No. 1 12
Morphine Sulfate Slow-Release Suppositories Vol. 1 No. 1 32
Morphine Suppositories Vol. 1 No. 1 36